key: cord-0810676-ec3jgtcg authors: Bahun, Miha; Jukić, Marko; Oblak, Domen; Kranjc, Luka; Bajc, Gregor; Butala, Matej; Bozovičar, Krištof; Bratkovič, Tomaž; Podlipnik, Črtomir; Poklar Ulrih, Nataša title: Inhibition of the SARS-CoV-2 3CL(pro) main protease by plant polyphenols date: 2021-11-14 journal: Food Chem DOI: 10.1016/j.foodchem.2021.131594 sha: 5039607749a4f96c664838fcb63b19affffb4977 doc_id: 810676 cord_uid: ec3jgtcg The abundance of polyphenols in edible plants makes them an important component of human nutrition. Considering the ongoing COVID-19 pandemic, a number of studies have investigated polyphenols as bioactive constituents. We applied in-silico molecular docking as well as molecular dynamics supported by in-vitro assays to determine the inhibitory potential of various plant polyphenols against an important SARS-CoV-2 therapeutic target, the protease 3CL(pro). Of the polyphenols in initial in-vitro screening, quercetin, ellagic acid, curcumin, epigallocatechin gallate and resveratrol showed IC(50) values of 11.8 µM to 23.4 µM. In-silico molecular dynamics simulations indicated stable interactions with the 3CL(pro) active site over 100 ns production runs. Moreover, surface plasmon resonance spectroscopy was used to measure the binding of polyphenols to 3CL(pro) in real time. Therefore, we provide evidence for inhibition of SARS-CoV-2 3CL(pro) by natural plant polyphenols, and suggest further research into the development of these novel 3CL(pro) inhibitors or biochemical probes. Abstract: The abundance of polyphenols in edible plants makes them an important component of 24 human nutrition. Considering the ongoing COVID-19 pandemic, a number of studies have investigated 25 polyphenols as bioactive constituents. We applied in-silico molecular docking as well as molecular 26 dynamics supported by in-vitro assays to determine the inhibitory potential of various plant 27 polyphenols against an important SARS-CoV-2 therapeutic target, the protease 3CL pro . Of the 28 polyphenols in initial in-vitro screening, quercetin, ellagic acid, curcumin, epigallocatechin gallate and 29 resveratrol showed IC 50 values of 11.8 µM to 23.4 µM. In-silico molecular dynamics simulations 30 indicated stable interactions with the 3CL pro active site over 100 ns production runs. Moreover, surface 31 plasmon resonance spectroscopy was used to measure the binding of polyphenols to 3CL pro in real 32 time. Therefore, we provide evidence for inhibition of SARS-CoV-2 3CL pro by natural plant polyphenols, 33 and suggest further research into the development of these novel 3CL pro inhibitors or biochemical 34 probes. (SARS-CoV-2), which was first reported in December 2019. In the early months of 2020, COVID-19 51 spread worldwide, to cause a pandemic . This first became a global health problem, 52 and then later a socioeconomic problem, and it has claimed >4 million lives to date. Importantly, 53 together with the relevant authorities, the medical and academic communities responded quickly, 54 with intensive research campaigns that were accompanied by proposals for social guidelines, hygiene 55 practices and the dissemination of quality information (Fry et al., 2020) . The SARS-CoV-2 virus belongs to the Coronaviridae family, and is named after its 'crown' serrations 57 (Kahn & McIntosh, 2005) . It is a single-stranded positive-sense RNA virus , and its 58 virulence ranges from a common cold to serious pathogenic potential, as demonstrated by the Polyphenols are a structurally diverse group of aromatic compounds that contain multiple hydroxyl 67 groups (Abbas et al., 2017) . These naturally occurring compounds are produced through secondary 68 metabolism in plants, where they are involved in defence mechanisms against pathogens and UV 69 radiation (Treuter, 2006) . Due to the abundance of polyphenols in edible plants, they constitute an 70 important part of the human diet (Williamson, 2017 The 3D structure of the SARS-CoV-2 3CL pro was obtained from the Protein Data Bank (PDB ID: 6M2N). 116 The structure of the 3D protein complex was solved at 2.20 Å using X-ray diffraction, as a homodimer 117 with an inhibitor (3WL; polyphenolic; 5,6,7-trihydroxy-2-phenyl-4H-chromen-4-one) bound to the 118 active sites (one binding site per subunit to define a physiological solution. After removing bumps/clashes using steepest descent minimisation, 141 annealing minimisation was used to reach a stable local energy minimum. From here, the simulation 142 was started by assigning random initial velocities and slowly heating the system to 298 K. A molecular 143 dynamics simulation was started using the AMBER14 force field for the solute, GAFF and AM1BCC 144 charges for the ligands, and TIP3P for the water. The temperature was set to 298 K at a pressure of 1 145 atm (NPT ensemble, Berendsen barostat and thermostat, coupled to time-averaged temperature and 146 density), with snapshots saved every 100 ps. Non-bonded long-range interactions were calculated 147 using the Particle Mesh Ewald algorithm. The Shake algorithm was not used, and the energy of the 148 system was stable throughout the production run, as was the root-mean-square deviation of the 149 protein backbone for all of the systems (details in Supplementary Materials Fig. S1 ). The production 150 run was performed over a period of 110 ns, with the first 10 ns serving to equilibrate the system. 151 The codon-optimised gene encoding SARS-CoV-2 3CL pro with an N-terminal 6×His tag and a TEV 153 protease cleavage site was obtained (Integrated DNA Technologies, USA) and cloned into the pET-154 28c(+) plasmid between the NcoI and NotI restriction sites. The cells were lysed by sonication on ice, and the insoluble cellular debris was removed by 165 centrifugation (15000× g for 10 min at 4 °C; repeated twice). The clarified supernatant was then filtered 166 to a 100-kDa molecular weight cut-off (Amicon Ultra-15 centrifugal filter units; Merck, Germany). The 167 filtrate was combined with 0.5 M (NH 4 ) 2 SO 4 (final concentration) and loaded onto a 1 mL HiTrap Phenyl 168 HP column (Cytiva, USA) that was pre-equilibrated with buffer B (50 mM Tris, pH 7.5, 0.5 M (NH 4 ) 2 SO 4 , 169 0.05 mM EDTA, 2.5 mM DTT, 10% glycerol). The column was then washed with 15 mL buffer B and the 170 3CL pro protein was eluted from the column using a linear gradient of 0% to 100% buffer A in buffer B. 171 The 3CL pro protein eluted as a broad peak at ~70% buffer A. The eluted 3CL pro was concentrated with a 172 30-kDa molecular weight cut-off (Ultra-4 centrifugal filter units; Amicon), snap-frozen in liquid 173 nitrogen, and stored at -80 °C. The purity of the isolated 3CL pro was assessed by SDS-PAGE using 12% 174 polyacrylamide gels. The concentration of 3CL pro was determined using absorbance at 280 nm and an 175 extinction coefficient of 34380 M -1 cm -1 (using the ProtParam bioinformatic tool). 176 177 The inhibitory activities of the polyphenols against 3CL pro were determined using the fluorescence to investigate whether they have the potential to bind to the active site of SARS-CoV-2 3CL pro . 240 Furthermore, we advocate their potential use as scaffolds or hits ideal for scaffold hopping, similarity 241 searches and further molecular optimisation. To this end, we performed additional blind pre-docking 242 analyses in which the polyphenols were docked as potential ligands to the entire 3CL pro protein without 243 prior knowledge of the binding sites. Error! Reference source not found.A shows that ligands can 244 generally interact with several different regions on the 3CL pro dimer structure, although the catalytic 245 site regions produced the most favourably scored binding poses. If focusing on the active site of 3CL pro , 246 Figure 2B demonstrates the identified ellagic acid calculated binding mode in the vicinity of the 247 catalytic Cys145. Polyphenol thus makes key six hydrogen bonds with the active site residues, namely: 248 Thr25, Gly143, Ser144, Cys145 and Glu166. Further π-π interaction can be observed between ligand To gain further insight into the compound interaction with the 3CL pro protein, we performed a plethora 277 of molecular dynamics simulations on calculated binding poses of examined polyphenols. We were 278 focusing on the stability of the complexes (see Supplementary Materials for details of all of the 279 complexes examined) and we therefore examined the conformational stability of the examined 280 polyphenols during the molecular dynamics production runs. We prepared an in-house script which 281 recorded the contact maps of each polyphenol during the production runs, with a total of 12 282 polyphenols at 100 ns each (1.2 µs production simulation time). From the contact maps, it was 283 observed that the major contacts that persevered through the simulation production time of all 284 examined polyphenols with the 3CL pro protein were towards the Met49, Glu166, Asp187 and Gln189, 285 placing the compounds at the entrance or in the P2 pocket of the 3CL pro active site. Further observed 286 major contacts were towards His41, Met165 and Glu166 at the P1 and P1' 3CL pro active site pockets. 287 The identified contacts (contact maps can be found in Supplementary Materials) therefore place the 288 polyphenols at the active site during the majority of the production runs, mainly at the P1-P1' pockets, 289 reaching also towards P2 subsite. Only two polyphenols: ferulic acid and resveratrol dissociated at the 290 beginning of molecular dynamics simulations at 10 and 12 ns respectively (see Supplementary 291 Materials for further details). Initially, 19 different polyphenols (Error! Reference source not found.) were screened for inhibitory 294 activity against 3CL pro at 10 µM, using the synthetic FRET substrate MCA-AVLQSGFR-Lys(Dnp)-Lys-NH 2 . 295 In these assays, the substrate and tested polyphenols were pre-mixed, and the reactions were initiated 296 by addition of 3CL pro . The hydrolysis of the substrate was followed continuously (see Supplementary 297 Materials Fig. S2 for further details), and the inhibitory activities of the polyphenols were determined 298 after 10 min. Half of the polyphenols showed <25% inhibition of 3CL pro , with syringic acid showing no 299 inhibition at all (Error! Reference source not found.). The majority of these weakly active polyphenols 300 were those composed of a single aromatic ring; these are classified as phenolic acids (quinic, 301 protocatechuic acids), hydroxycinnamic acids (sinapic, ferulic, caffeic, umbellic acids), phenylacetic 302 acids (4-hydroxy-3-nitrophenylacetic acid) and phenolic acid esters (chlorogenic acid) (Error! 303 Reference source not found.). Greater inhibitory activities were seen for the polyphenols of the 304 flavonoid class (isorhamnetin, phlorizin, galangin, kaempferol), which showed 25% to 50% inhibition 305 of 3CL pro activity (Error! Reference source not found.). Of note, the glycosylated kaempferol analogue, 306 kaempferol-3-rutinoside, showed significantly less 3CL pro inhibition (18%) compared to kaempferol 307 (45%). This implies that the sugar moiety of kaempferol-rutinoside decreases its binding to the 3CL pro 308 active site. Five of the polyphenols showed >50% 3CL pro inhibition: quercetin, ellagic acid, curcumin, 309 EGCG and resveratrol (Error! Reference source not found.). Interestingly, these compounds differ 310 significantly in their structures and belong to distinct polyphenol subclasses; i.e., the flavonols 311 (quercetin), flavanols (EGCG), hydroxybenzoic acid derivatives (ellagic acid), curcuminoids (curcumin) 312 and stilbenes (resveratrol) (Error! Reference source not found.). Epigallocatechin gallate, ellagic acid, curcumin, resveratrol and quercetin were subjected to further 320 dose-response studies, to determine the concentrations required to inhibit 3CL pro activity by 50% (IC 50 ). 321 Those polyphenols were selected on the basis of their relatively high inhibitory activities in the initial 322 in-vitro screening (Fig. 3) . For determination of the IC 50 values, increasing concentrations of these 323 polyphenols were incubated with 3CL pro before the addition of the FRET substrate, and the 324 fluorescence signals were determined 2 h later. The IC 50 values for EGCG, ellagic acid, curcumin, 325 resveratrol and quercetin were 13.9 µM, 11.8 µM, 11.9 µM, 16.9 µM and 23.4 µM, respectively (Error! 326 Reference source not found.). Thus, the potencies of these selected polyphenols for 3CL pro inhibition 327 were similar in this study. Of note, none of these polyphenols perturbed the secondary structure of 328 3CL pro to any great extent (see Supplementary Materials Fig. S3 for further details) . Therefore, the 329 inhibition of 3CL pro by these polyphenols appears to be due to their block of the 3CL pro active site, and 330 not due to disruption of the conformation of 3CL pro . These IC 50 values are comparable to, or lower than, 331 those of the compounds that were identified as the top five SARS-CoV-2 3CL pro inhibitors among the 332 3987 US Food and Drug Administration approved drugs in a study by Mody et al. (2021) . Of these five polyphenols that showed the greatest inhibition of SARS-CoV-2 3CL pro in the present 334 study, only quercetin and EGCG had been examined previously in in-vitro inhibition analyses of this 335 protease. Quercetin was previously identified as the most potent inhibitor of SARS-CoV-2 3CL pro among 336 150 different compounds screened in-vitro, with an inhibition constant (K i ) estimated at 7.4 µM (Abian 337 et al., 2020). This is in a similar range to the quercetin IC 50 determined in the present study (23.4 µM) 338 (Error! Reference source not found.). An IC 50 for EGCG that was reported recently (0.056 µM) (Du et 339 al., 2021) was considerably lower than that in the present study (13.9 µM) (Error! Reference source Interestingly, EGCG appears to inhibit SARS-CoV-2 3CL pro more strongly than SARS-CoV 3CL pro , which 342 was demonstrated previously (Chiou et al., 2021) . Resveratrol and curcumin were among these five strongest SARS-CoV-2 3CL pro inhibitors in the present 344 study (Error! Reference source not found.), and these are also widely known natural compounds with 345 antiviral activities ( shown to inhibit SARS-CoV 3CL pro in-vitro (Ryu et al., 2010) , and was also predicted to bind stably into 349 the SARS-CoV-2 3CL pro active site in-silico (Huynh et al., 2020) . To the best of our knowledge, no 350 previous studies have investigated the inhibition of SARS-CoV-2 by curcumin and resveratrol in-vitro. 351 Ellagic acid is a tetracyclic polyphenol that is abundant in berries and nuts (Daniel et al., 1989) , and it 352 was also previously predicted to inhibit SARS-CoV-2 3CL pro , although only in-silico (Khalifa et al., 2020, 353 Ni The binding of the selected polyphenols to 3CL pro was further studied using SPR spectroscopy, which 363 allowed measurement of their interactions in real time. Here, the interactions were examined for three 364 polyphenols that showed high 3CL pro inhibitory activities, as EGCG, ellagic acid, and resveratrol, and for 365 two polyphenols that showed weak or no 3CL pro inhibitory activities in the initial in-vitro screening 366 (Error! Reference source not found.), as syringic acid and caffeic acid. Although curcumin and 367 quercetin were also among the most potent 3CL pro inhibitors identified here, they were not examined 368 by SPR due to their low solubilities. Epigallocatechin gallate, ellagic acid and resveratrol bound to the 3CL pro immobilised on the chip (Error! 370 Reference source not found.). Sensorgrams of EGCG and resveratrol with 3CL pro indicated rapid 371 association and dissociation of these polyphenols. The responses of EGCG and resveratrol did not reach 372 plateaus even with these polyphenols at 200 µM. Together with the fitting of the sensorgrams to 373 steady-state kinetics (see Supplementary Materials Fig. S4 for more details), this SPR analysis 374 suggested non-specific binding of EGCG and resveratrol to 3CL pro . In contrast, the two-state kinetics 375 model provided a fit for the ellagic acid-3CL pro interaction, which indicated a K D of 311 ±69 µM. The 376 sensorgrams suggested that the association of ellagic acid with 3CL pro is slower than that of EGCG and 377 resveratrol, and it can be noted that the dissociation of ellagic acid from 3CL pro appeared to occur in 378 two steps, as an initial rapid decrease in the SPR response that was followed by a slow dissociation. 379 This is likely to be the consequence of multiple ellagic acid binding sites on 3CL pro with different 380 affinities. Syringic and caffeic acids only bound weakly to 3CL pro , with EGCG, ellagic acid and resveratrol 381 showing 10-fold higher RU values (Error! Reference source not found.). This is consistent with the low 382 inhibitory activity of syringic and caffeic acids towards 3CL pro . We initially developed a consensus docking approach that resulted in a library enrichment of 2.5-fold, 392 which was determined by the biological evaluation in the following step. IC 50 values were obtained for 393 EGCG, curcumin, resveratrol, quercetin and ellagic acid of 13.9 µM, 11.9 µM, 16.9 µM, 23.4 µM and 394 11.8 µM, respectively. Further in-silico molecular dynamics studies indicated labile interactions for 395 resveratrol, while they produced stable binding conformations at the active site of 3CL pro for the other 396 four polyphenols. EGCG showed hydrophobic interactions with 3CL pro residues Met49, Met165 and 397 Gln189, and hydrogen bonds with residues Asp187 and Glu166. Curcumin formed hydrogen bonds 398 with 3CL pro residues Gln192 and Arg188. Ellagic acid occupied a binding mode at the active site of 399 3CL pro , with hydrogen bonds with residues Cys44, Asn142, His164 and Gln189, and it formed 400 hydrophobic interactions with residues Asn142, Cys145, Met165 and Met166, and π-π stacking with 401 His41. The binding of ellagic acid to 3CL pro was confirmed by SPR using a two-state kinetics model, with 402 a measured K D of 311 ±69 µM. We have therefore demonstrated that ellagic acid as a low micromolar 403 SARS-CoV-2 3CL pro inhibitor that is suitable for further crystallographic studies. This study also enables 404 the use of ellagic acid and similar polyphenols for scaffold hopping and similarity searches and 405 optimisation, with a view to new potential SARS-CoV-2 inhibitors or novel molecular probes. Natural polyphenols: an overview Structural stability of SARS-CoV-2 3CLpro and identification of 421 quercetin as an inhibitor by experimental screening New substructure filters for removal of pan assay interference 424 compounds (PAINS) from screening libraries and for their exclusion in bioassays Polyphenols inhibit hepatitis C virus entry by a new 429 mechanism of action Antiviral activity of resveratrol The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease. Biochemical and 435 Biophysical Research Communications Structure-based design of 438 antiviral drug candidates targeting the SARS-CoV-2 main protease Extraction, 441 stability, and quantitation of ellagic acid in various fruits and nuts SARS and MERS: recent insights 444 into emerging coronaviruses Epigallocatechin-3-gallate, an active 447 ingredient of traditional Chinese medicines, inhibits the 3CL pro activity of SARS-CoV-2. 448 Polyphenols are potential nutritional 451 adjuvants for targeting COVID-19 Extra precision glide: Docking and scoring incorporating a model of hydrophobic 455 enclosure for protein−ligand complexes Consolidation in a crisis: patterns of international 458 collaboration in early COVID-19 research Phenolic compounds disrupt Spike-mediated 461 receptor binding and entry of SARS-CoV-2 Consensus docking: improving the reliability of docking in 464 a virtual screening context In-silico exploration of the molecular mechanism of clinically 467 oriented drugs for possibly inhibiting SARS-CoV-2 main protease In silico and in vitro evaluation of kaempferol as a potential inhibitor of the SARS-CoV-2 main 471 protease (3CLpro) Mutagenesis-Based Remodelling of SARS-CoV-1 Peptide (ATLQAIAS) to Inhibit SARS-CoV-2: 475 Structural-Dynamics and Free Energy Calculations. Interdisciplinary Sciences: Computational Life 476 Sciences History and recent advances in coronavirus discovery Tannins inhibit SARS-CoV-2 through 481 binding with catalytic dyad residues of 3CL pro : an in-silico approach with 19 structural different 482 hydrolysable tannins Inhibition of influenza virus replication by plant-derived 485 isoquercetin New ways to boost molecular dynamics simulations Antiviral potential of curcumin Polyphenols 491 as promising biologically active substances for preventing SARS-CoV-2: a review with research 492 evidence and underlying mechanisms Identification of 3-chymotrypsin like protease (3CL pro ) inhibitors as potential CoV-2 agents Study on the mechanism of active components of Liupao tea on 3CL pro based 500 on HPLC-DAD fingerprint and molecular docking technique Potential use of polyphenols in the battle against 503 COVID-19. Current Opinion in Food Science Resveratrol inhibits HCoV-229E and SARS-CoV-2 coronavirus 507 replication in vitro Polyphenols and their benefits: a review. 509 Rutin Is a low micromolar inhibitor 513 of SARS-CoV-2 main protease 3CL pro : implications for drug design of quercetin analogs rDock: 516 a fast, versatile and open source program for docking ligands to proteins and nucleic acids SARS-CoV 3CL pro inhibitory effects of quinone-methide triterpenes from Tripterygium 520 regelii Potential therapeutic options for COVID-19: current status, challenges, and future perspectives. 524 Frontiers in Pharmacology Significance of flavonoids in plant resistance: a review AutoDock VINA: improving the speed and accuracy of docking with a 528 new scoring function, efficient optimization, and multithreading A novel coronavirus outbreak of global 531 health concern. The Lancet The role of polyphenols in modern nutrition Resveratrol inhibits the replication of severe acute respiratory syndrome coronavirus 2 (SARS-537 CoV-2) in cultured Vero cells Swine enteric alphacoronavirus (swine acute diarrhea 540 syndrome coronavirus): an update three years after its discovery A novel coronavirus from 543 patients with pneumonia in China